Ultragenyx Pharmaceutical Inc.
USD30.68
-0.09 (-0.29%)
CEO
Emil D. Kakkis
IPO Date
2014-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$30.77
Prev. Close
$30.77
Day Low
$30.19
Day High
$31.16
52W Low
$18.29
52W High
$42.37
Market Cap
$3.02B
Volume
3.92M
| 31 Dec 2023 | FY | 89.6% | -139.7% | -220.3% | -40.7% | 0.16 | 2.61 | -5.8 |
| 31 Dec 2022 | FY | 92.2% | -194.7% | -200.7% | -45.8% | 0.09 | 3.38 | -4.6 |
| 31 Dec 2021 | FY | 95.4% | -129.2% | -49.2% | -29.8% | 0.05 | 4.72 | -12.6 |
| 31 Dec 2020 | FY | 97.7% | -68.8% | -16.2% | -10.6% | 0.04 | 6.83 | -45.1 |
| 31 Dec 2019 | FY | 91.3% | -388.3% | -61.6% | -35.5% | 0.06 | 8.24 | -6.0 |
| 31 Dec 2018 | FY | 97.8% | -383.7% | -32.5% | -27.5% | 0.00 | 6.99 | -11.0 |
| 31 Dec 2017 | FY | 100.0% | -11567.3% | -78.8% | -61.6% | 0.00 | 3.44 | -6.5 |
| 31 Dec 2016 | FY | -137647.4% | -184867.7% | -51.9% | -45.5% | 0.00 | 8.27 | -11.3 |
| -4.5 |
| 30 Sept 2025 | Q3 | 82.5% | -112.8% | -1969.8% | -15.2% | 96.60 | 1.89 | -4.2 |
| 30 Jun 2025 | Q2 | 86.2% | -69.0% | -76.0% | -8.8% | 0.24 | 2.45 | -7.8 |
| 31 Mar 2025 | Q1 | 79.4% | -108.5% | -104.7% | -11.5% | 0.27 | 2.40 | -5.8 |
| 31 Dec 2024 | Q4 | 89.8% | -80.9% | -52.2% | -8.9% | 0.16 | 2.37 | -7.5 |
| 30 Sept 2024 | Q3 | 84.9% | -95.7% | -38.5% | -8.7% | 0.10 | 2.81 | -9.9 |
| 30 Jun 2024 | Q2 | 85.5% | -89.5% | -30.4% | -8.1% | 0.09 | 3.54 | -6.8 |
| 31 Mar 2024 | Q1 | 83.9% | -156.8% | -121.7% | -13.1% | 0.29 | 2.43 | -5.8 |
| 31 Dec 2023 | Q4 | 90.5% | -96.7% | -44.7% | -8.3% | 0.16 | 2.61 | -7.9 |